首页> 外文期刊>Case Reports in Pathology >Rare Testicular Tumor Discovered by Assault: An Unusual Presentation of a Primary Testicular Neuroendocrine Tumor Grade 2
【24h】

Rare Testicular Tumor Discovered by Assault: An Unusual Presentation of a Primary Testicular Neuroendocrine Tumor Grade 2

机译:突袭发现罕见的睾丸肿瘤:2级原发性睾丸神经内分泌肿瘤的异常表现。

获取原文
           

摘要

Testicular neuroendocrine tumors (NET) or carcinoid tumors are rare neoplasms which represent 1% of all testicular tumors and can be divided into 3 subgroups: pure primary testicular NET, primary testicular NET associated with a teratoma, and NET metastases to the testis. We report an unusual presentation of a primary testicular neuroendocrine tumor in a 39-year-old male who presented after a physical altercation during a soccer game. Histology showed a diffuse infiltrating tumor with extensive involvement of the tunica albuginea and tunica vaginalis. Immunohistochemical expression of CD56, synaptophysin, and chromogranin A was strongly positive in the tumor cells. Foci of tumor cell necrosis and occasional mitotic figures as well as extensive lymph-vascular invasion were also identified. A review of the literature reveals differing opinions on the prognostic significance of primary tumor size, mitotic index, tumor necrosis, and nuclear atypia. In our patient, the increased mitotic rate (3–5 mitotic figures per 10 hpf and a Ki-67 index of 5%), foci of necrosis, and mild to moderate nuclear atypia warranted a diagnosis of neuroendocrine tumor grade 2, formerly atypical carcinoid. Long term surveillance in these patients is essential as metastasis occurs in up to 15% of cases. At the 6-month followup, the patient remains symptom free.
机译:睾丸神经内分泌肿瘤(NET)或类癌肿瘤是罕见的肿瘤,占所有睾丸肿瘤的1%,可分为3个亚组:纯原发性睾丸NET,与畸胎瘤相关的原发性睾丸NET和转移至睾丸的NET。我们报告了一位足球运动员在体育比赛中发生身体争执后出现的39岁男性原发性睾丸神经内分泌肿瘤的异常表现。组织学显示弥漫性浸润性肿瘤,白膜和阴道膜广泛参与。 CD56,突触素和嗜铬粒蛋白A的免疫组织化学表达在肿瘤细胞中强烈阳性。还确定了肿瘤细胞坏死灶和偶发有丝分裂图以及广泛的淋巴管浸润。文献综述揭示了对原发肿瘤大小,有丝分裂指数,肿瘤坏死和核非典型性预后意义的不同意见。在我们的患者中,有丝分裂率增加(每10 hpf 3-5个有丝分裂图和5%的Ki-67指数),坏死灶和轻度至中度核非典型性,可确诊为神经内分泌肿瘤2级,以前是非典型类癌。 。这些患者中的长期监测至关重要,因为多达15%的病例发生转移。在6个月的随访中,患者保持无症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号